CTSO Stock Summary and Trading Ideas (Cytosorbents | NASDAQ:CTSO)

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

What symbol and exchange does Cytosorbents shares trade?

Cytosorbents trades on the NASDAQ stock market under the symbol CTSO.

What is Cytosorbents stock price doing today?

As of April 10, 2026, CTSO stock price climbed to $0.61 with 42,470 million shares trading.

What is Cytosorbents's Beta?

CTSO has a beta of 1.23, meaning it tends to be more sensitive to market movements. CTSO has a correlation of 0.07 to the broad based SPY ETF.

How much is Cytosorbents worth?

CTSO has a market cap of $38.28 million. This is considered a Sub-Micro Cap stock.

How much money does Cytosorbents make?

Last quarter Cytosorbents reported $9 million in Revenue and -$.07 earnings per share. This beat revenue expectation by $25,000 and missed earnings estimates by -$.02.

What is the highest and lowest price Cytosorbents traded in the last 3 year period?

In the last 3 years, CTSO traded as high as $4.29 and as low as $.50.

What are the top ETFs holding Cytosorbents?

The top ETF exchange traded funds that CTSO belongs to (by Net Assets): VTI, VXF, IWC, MSSM.

Is Cytosorbents (CTSO) a good investment?

CTSO has underperformed the market in the last year with a price return of -35.1% while the SPY ETF gained +30.9%. CTSO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -9.1% and +2.9%, respectively, while the SPY returned -1.8% and +7.2%, respectively.

What are the support and resistance levels for Cytosorbents (CTSO)?

CTSO support price is $.56 and resistance is $.65 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTSO shares will trade within this expected range on the day.